In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Shark cartilage/cancer study

This article was originally published in The Tan Sheet

Executive Summary

Shark cartilage/cancer study: Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancers finds that "shark cartilage was inactive in patients with advanced stage cancer and, specifically, in patients with breast, colon, lung and prostate cancer," Dennis Miller, Cancer Treatment Research Foundation, Arlington Heights, Ill., et al. concludes. The trial, the largest reported to date, entered 58 adults: 15 with breast cancer; 15 with colon cancer; 14, lung; eight, prostate; three, lymphoma; one, brain; and two, unknown. The abstract was presented at the annual meeting of the American Society of Clinical Oncology May 17-20 in Denver, Colo...





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts